Clinical Trial Detail

NCT ID NCT03026517
Title Clinical Trial of Phenformin in Combination With Dabrafenib and Trametinib for Patients With BRAF-mutated Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

melanoma

Therapies

Dabrafenib + Phenformin + Trametinib

Age Groups: adult senior

Additional content available in CKB BOOST